The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection
Open accessAbstract
BACKGROUND & AIMS: Fecal microbiota transplantation (FMT) is a highly effective therapy for recurrent Clostridium difficile infection (CDI). However, transferring undefined living bacteria entails uncontrollable risks for infectious and metabolic or malignant diseases, particularly in immunocompromised patients. We investigated whether sterile fecal filtrates (containing bacterial debris, proteins, antimicrobial compounds, metabolic products, and oligonucleotides/DNA), rather than intact microorganisms, are effective in patients with CDI. METHODS: We performed a clinical case series to investigate the effects of fecal filtrate transfer (FFT) in 5 patients with symptomatic chronic-relapsing CDI at the Department of Internal Medicine I at the University Hospital Schleswig-Holstein (Kiel, Germany). Patients were followed up for at least 6 months and for up to 33 months. Stool was collected from 5 donors selected by the patients, and fully characterized according to FMT standards. Stool was sterile-filtered to remove small particles and bacteria; the filtrate was transferred to patients in a single administration via nasojejunal tube. Fecal samples were collected from patients before and at 1 week and 6 weeks after FFT. Microbiome, virome, and proteome profiles of donors and patients were compared. RESULTS: In all 5 patients, FFT restored normal stool habits and eliminated symptoms of CDI for a minimum period of 6 months. Proteome analyses of selected FFT filtrates showed no obvious protein candidates associated with therapeutic efficacy. 16S ribosomal RNA gene sequencing detected diverse bacterial DNA signatures in the filtrates. Analysis of virus-like particles from a filtrate found to reduce symptoms of CDI showed a complex signature of bacteriophages. Bacterial phylogeny and virome profile analyses of fecal samples from recipients indicated longitudinal changes in microbial and viral community structures after FFT. CONCLUSIONS: A preliminary investigation of 5 patients with CDI shows that transfer of sterile filtrates from donor stool (FFT), rather than fecal microbiota, can be sufficient to restore normal stool habits and eliminate symptoms. This finding indicates that bacterial components, metabolites, or bacteriophages mediate many of the effects of FMT, and that FFT might be an alternative approach, particularly for immunocompromised patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Following successful treatment of C. difficile infection by FFT transplantation, the gut microbiota of a patient with loss of renal function resembled that of the faecal donor with remarkable elimination of Proteobacteria, which had dominated before FFT226.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [226]
In the citing paper
“The risk of secondary infection may be lower with FFT than with FMT, as FFT does not involve the transfer of live bacteria226.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [226]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 21,481
PAST: PALEONTOLOGICAL STATISTICAL SOFTWARE PACKAGE FOR EDUCATION AND DATA ANALYSIS
Hammer, Ø., Harper, D. A. T., & Ryan, P. D. (2001) · Palaeontologia Electronica · Cited by 17,871
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Fadrosh, D. W., Ma, B., Gajer, P., Sengamalay, N., Ott, S., Brotman, R. M., & Ravel, J. (2014) · Microbiome · doi:10.1186/2049-2618-2-6 · Cited by 1,698
Self-citationAssembling Single-Cell Genomes and Mini-Metagenomes From Chimeric MDA Products
Nurk, S., Bankevich, A., Antipov, D., Gurevich, A. A., Korobeynikov, A., Lapidus, A. L., Prjibelski, A. D., Pyshkin, A., Sirotkin, A., Sirotkin, Y., et al. (2013) · Journal of Computational Biology · doi:10.1089/cmb.2013.0084 · Cited by 1,352
Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
Norman, J. M., Handley, S. A., Baldridge, M. T., Droit, L., Liu, C. Y., Keller, B. C., Kambal, A., Monaco, C. L., Zhao, G., Fleshner, P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.002 · Cited by 1,285
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Reyes, 2010, Viruses in the faecal microbiota of monozygotic twins and their mothers, Nature, 466, 334, 10.1038/nature09199 · DOI
Cited by
Sorted by citations
Items 101–200 of 697
The role of the gut microbiota in the treatment of inflammatory bowel diseases
Aggeletopoulou, I., Konstantakis, C., Assimakopoulos, S. F., & Triantos, C. K. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103774 · Cited by 107
The Human Gut Phageome: Origins and Roles in the Human Gut Microbiome
Townsend, E. M., Kelly, L., Muscatt, G., Box, J. D., Hargraves, N., Lilley, D., & Jameson, E. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.643214 · Cited by 108
Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease
Tomofuji, Y., Kishikawa, T., Maeda, Y., Ogawa, K., Nii, T., Okuno, T., Oguro-Igashira, E., Kinoshita, M., Yamamoto, K., Sonehara, K., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221267 · Cited by 99
Sinha, A., Li, Y., Mirzaei, M. K., Shamash, M., Samadfam, R., King, I. L., & Maurice, C. F. (2022) · Microbiome · doi:10.1186/s40168-022-01275-2 · Cited by 101
Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection
D’Haens, G., & Jobin, C. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.053 · Cited by 104
The Gut-Liver Axis in Cholestatic Liver Diseases
Blesl, A., & Stadlbauer, V. (2021) · Nutrients · doi:10.3390/nu13031018 · Cited by 102
Draper, L. A., Ryan, F. J., Dalmasso, M., Casey, P. G., McCann, A., Velayudhan, V., Ross, R. P., & Hill, C. (2020) · BMC Biology · doi:10.1186/s12915-020-00906-0 · Cited by 98
Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome
Leshem, A., Horesh, N., & Elinav, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01341 · Cited by 96
Gut virome in inflammatory bowel disease and beyond
Tun, H. M., Peng, Y., Massimino, L., Sin, Z. Y., Parigi, T. L., Facoetti, A., Rahman, S., Danese, S., & Ungaro, F. (2023) · Gut · doi:10.1136/gutjnl-2023-330001 · Cited by 101
Nale, J. Y., Redgwell, T. A., Millard, A. D., & Clokie, M. R. J. (2018) · Antibiotics · doi:10.3390/antibiotics7010013 · Cited by 93
The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome
Yu, Y., Wang, W., & Zhang, F. (2023) · Advanced Science · doi:10.1002/advs.202301097 · Cited by 105
Shining Light on Human Gut Bacteriophages
Guerin, E., & Hill, C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00481 · Cited by 88
Littmann, E. R., Lee, J.-J., Denny, J. E., Alam, Z., Maslanka, J. R., Zarin, I., Matsuda, R., Carter, R. A., Susac, B., Saffern, M. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20793-x · Cited by 88
The old friends hypothesis: evolution, immunoregulation and essential microbial inputs
Rook, G. A. W. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1220481 · Cited by 95
“I will survive”: A tale of bacteriophage-bacteria coevolution in the gut
Sordi, L. D., Lourenço, M., & Debarbieux, L. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1474322 · Cited by 89
Roles of the gut virome and mycobiome in faecal microbiota transplantation
Lam, S., Bai, X., Shkoporov, A. N., Park, H., Wu, X., Lan, P., & Zuo, T. (2022) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00303-4 · Cited by 89
The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications
Bai, G.-H., Lin, S., Hsu, Y., & Chen, S.-Y. (2022) · Viruses · doi:10.3390/v14020278 · Cited by 93
Kim, T. T., Parajuli, N., Sung, M. M. Y., Bairwa, S. C., Levasseur, J. L., Soltys, C.-L. M., Wishart, D. S., Madsen, K. L., Schertzer, J. D., & Dyck, J. R. B. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2017 · Cited by 86
Kaelin, E. A., Rodríguez, C., Hall-Moore, C. M., Hoffmann, J. A., Linneman, L. A., Ndao, I. M., Warner, B. B., Tarr, P. I., Holtz, L. R., & Lim, E. S. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01096-x · Cited by 85
Yadegar, A., Pakpour, S., Ibrahim, F. F., Nabavi-Rad, A., Cook, L. E., Walter, J., Seekatz, A. M., Wong, K., Monaghan, T. M., & Kao, D. H. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.019 · Cited by 90
Mouse Vendor Influence on the Bacterial and Viral Gut Composition Exceeds the Effect of Diet
Rasmussen, T. S., de Vries, L., Kot, W., Hansen, L. H., Castro-Mejía, J. L., Vogensen, F. K., Hansen, A. K., & Nielsen, D. S. (2019) · Viruses · doi:10.3390/v11050435 · Cited by 85
Functional Restoration of Bacteriomes and Viromes by Fecal Microbiota Transplantation
Fujimoto, K., Kimura, Y., Allegretti, J. R., Yamamoto, M., Zhang, Y., Katayama, K., Tremmel, G., Kawaguchi, Y., Shimohigoshi, M., Hayashi, T., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.013 · Cited by 85
Phage Therapy in Gastrointestinal Diseases
Gutiérrez, B., & Domingo‐Calap, P. (2020) · Microorganisms · doi:10.3390/microorganisms8091420 · Cited by 89
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Hou, S., Yu, J., Li, Y., Zhao, D., & Zhang, Z. (2025) · Advanced Science · doi:10.1002/advs.202413197 · Cited by 97
The Safety of Fecal Microbiota Transplantation for Crohn’s Disease: Findings from A Long-Term Study
Wang, H., Cui, B., Li, Q., Ding, X. L., Li, P., Zhang, T., Yang, X., Ji, G., & Zhang, F. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0800-3 · Cited by 88
Therapies to modulate gut microbiota: Past, present and future
Gupta, A., Saha, S., & Khanna, S. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i8.777 · Cited by 84
The gut virome is associated with stress-induced changes in behaviour and immune responses in mice
Ritz, N. L., Draper, L. A., Bastiaanssen, T. F. S., Turkington, C. J. R., Peterson, V. L., van de Wouw, M., Vlčková, K., Fülling, C., Guzzetta, K. E., Burokas, A., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01564-y · Cited by 88
Viruses and Evolution – Viruses First? A Personal Perspective
Moelling, K., & Broecker, F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00523 · Cited by 90
Phages in the infant gut: a framework for virome development during early life
Shamash, M., & Maurice, C. F. (2021) · The ISME Journal · doi:10.1038/s41396-021-01090-x · Cited by 81
Kao, D., Wong, K., Franz, R., Cochrane, K., Sherriff, K., Chui, L., Lloyd, C., Roach, B., Bai, A. D., Petrof, E. O., et al. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00007-8 · Cited by 81
Iyer, N. R., & Corr, S. C. (2021) · Nutrients · doi:10.3390/nu13124259 · Cited by 83
Integrating Viral Metagenomics into an Ecological Framework
Sommers, P. N., Chatterjee, A., Varsani, A., & Trubl, G. (2021) · Annual Review of Virology · doi:10.1146/annurev-virology-010421-053015 · Cited by 79
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N. B., Iqbal, T. H., et al. (2018) · Journal of Hospital Infection · doi:10.1016/j.jhin.2018.07.037 · Cited by 79
Baumgartner, M., Bayer, F., Pfrunder‐Cardozo, K. R., Buckling, A., & Hall, A. R. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000465 · Cited by 77
The human gut virome: composition, colonization, interactions, and impacts on human health
Pargin, E., Roach, M. J., Skye, A., Papudeshi, B. N., Inglis, L. K., Mallawaarachchi, V., Grigson, S. R., Harker, C. M., Edwards, R. A., & Giles, S. K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.963173 · Cited by 86
Horizon scanning the application of probiotics for wildlife
Garcías-Bonet, N., Roik, A., Tierney, B. T., García, F. C., Villela, H., Dungan, A. M., Quigley, K. M., Sweet, M. J., Berg, G., Gram, L., et al. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.08.012 · Cited by 81
The role of the microbiome in gastrointestinal inflammation
Sanders, D. J., Inniss, S., Sebepos‐Rogers, G., Rahman, F. Z., & Smith, A. M. (2021) · Bioscience Reports · doi:10.1042/bsr20203850 · Cited by 82
Impact of gut microbiota on gut‐distal autoimmunity: a focus on T cells
Sprouse, M. L., Bates, N. A., Felix, K. M., & Wu, H.-J. J. (2018) · Immunology · doi:10.1111/imm.13037 · Cited by 79
THE INTESTINAL MICROBIOME IN HUMAN HEALTH AND DISEASE.
DuPont, H. L., Jiang, Z., Dupont, A. W., & Utay, N. S. (2020) · PubMed · Cited by 78
Borody, T. J., Eslick, G. D., & Clancy, R. L. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.04.017 · Cited by 64
Clinical translation of microbe‐based therapies: Current clinical landscape and preclinical outlook
Vargason, A. M., & Anselmo, A. C. (2018) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10093 · Cited by 71
Roles of the intestinal microbiota and microbial metabolites in acute GVHD
Lin, D., Hu, B., Li, P., Zhao, Y., Xu, Y., & Wu, D. (2021) · Experimental Hematology & Oncology · doi:10.1186/s40164-021-00240-3 · Cited by 71
Kigerl, K. A., Zane, K., Adams, K., Sullivan, M. B., & Popovich, P. G. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113085 · Cited by 70
Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease
Basson, A. R., Zhou, Y., Seo, B., Rodriguez‐Palacios, A., & Cominelli, F. (2020) · Translational research · doi:10.1016/j.trsl.2020.05.008 · Cited by 74
Encapsulation and delivery of phage as a novel method for gut flora manipulation in situ: A review
Yang, Y., Du, H., Zou, G., Song, Z., Zhou, Y., Li, H., Tan, C. S., Chen, H., Fischetti, V. A., & Li, J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.048 · Cited by 70
Amrane, S., Hocquart, M., Afouda, P., Kuete, E., Pham, T.-P.-T., Dione, N., Ngom, I. I., Valles, C., Bachar, D., Raoult, D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49189-8 · Cited by 68
Bikel, S., López-Leal, G., Cornejo‐Granados, F., Gallardo-Becerra, L., García-López, R., Sánchez, F., Equihua-Medina, E., Ochoa‐Romo, J. P., López-Contreras, B. E., Canizales‐Quinteros, S., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102900 · Cited by 68
Capturing the environment of the Clostridioides difficile infection cycle
Schnizlein, M. K., & Young, V. B. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00610-0 · Cited by 63
Stability of the human gut virome and effect of gluten-free diet
Garmaeva, S., Gulyaeva, A. A., Sinha, T., Shkoporov, A. N., Clooney, A. G., Stockdale, S. R., Spreckels, J. E., Sutton, T., Draper, L. A., Dutilh, B. E., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109132 · Cited by 69
Kaito, S., Toya, T., Yoshifuji, K., Kurosawa, S., Inamoto, K., Takeshita, K., Suda, W., Kakihana, K., Honda, K., Hattori, M., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018024968 · Cited by 66
Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank
Chen, J., Zaman, A., Ramakrishna, B., OpenBiome Team, & Olesen, S. W. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.622949 · Cited by 68
Wortelboer, K., de Jonge, P. A., Scheithauer, T. P. M., Attaye, I., Kemper, E. M., Nieuwdorp, M., & Herrema, H. (2023) · Nature Communications · doi:10.1038/s41467-023-41329-z · Cited by 63
Martínez-Gili, L., McDonald, J. A. K., Liu, Z., Kao, D. H., Allegretti, J. R., Monaghan, T. M., Barker, G. F., Blanco, J. M., Williams, H. R. T., Holmes, E. C., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1810531 · Cited by 65
The Presence of Bacteriophages in the Human Body: Good, Bad or Neutral?
Łusiak-Szelachowska, M., Weber‐Dąbrowska, B., Żaczek, M., Borysowski, J., & Górski, A. (2020) · Microorganisms · doi:10.3390/microorganisms8122012 · Cited by 62
Microbiota Replacement Therapies: Innovation in Gastrointestinal Care
Khanna, S. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.923 · Cited by 65
Lin, D. M., Koskella, B. L., Ritz, N. L., Lin, D., Carroll‐Portillo, A., & Lin, H. C. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00348 · Cited by 61
Zu, M., Liu, G., Xu, H., Zhu, Z., Zhen, J., Li, B., Shi, X., Shahbazi, M., Reis, R. L., Kundu, S. C., et al. (2024) · Advanced Materials · doi:10.1002/adma.202409138 · Cited by 63
Sieving through gut models of colonization resistance
Mullineaux-Sanders, C., Suez, J., Elinav, E., & Frankel, G. M. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0095-1 · Cited by 61
Kazemian, N., Ramezankhani, M., Sehgal, A., Khalid, F. M., Kalkhoran, A. H. Z., Narayan, A., Wong, G. K.-S., Kao, D., & Pakpour, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-75162-x · Cited by 61
Tavoukjian, V. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.03.010 · Cited by 65
Conceptual Design of a Universal Donor Screening Approach for Vaginal Microbiota Transplant
DeLong, K., Bensouda, S., Zulfiqar, F., Zierden, H. C., Hoang, T., Abraham, A. G., Coleman, J. S., Cone, R. A., Gravitt, P. E., Hendrix, C. W., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00306 · Cited by 62
The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
Mullish, B. H., & Allegretti, J. R. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211017725 · Cited by 61
The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts
Liwinski, T., Heinemann, M., & Schramm, C. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00936-6 · Cited by 60
Framework for rational donor selection in fecal microbiota transplant clinical trials
Duvallet, C., Zellmer, C., Panchal, P., Budree, S., Osman, M., & Alm, E. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222881 · Cited by 59
Dowdell, A. S., & Colgan, S. P. (2021) · Pharmaceuticals · doi:10.3390/ph14080708 · Cited by 55
Goldenberg, S. D., Batra, R., Beales, I., Digby-Bell, J. L., Irving, P. M., Kellingray, L., Narbad, A., & Elumogo, N. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0189-y · Cited by 56
Hirten, R. P., Grinspan, A. M., Fu, S., Luo, Y., Suárez‐Fariñas, M., Rowland, J., Contijoch, E. J., Mogno, I., Yang, N., Luong, T., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy398 · Cited by 54
Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease
Marônek, M., Link, R., Ambro, Ľ., & Gardlík, R. (2020) · Cells · doi:10.3390/cells9041013 · Cited by 54
Bacteriophage-Bacteria Interactions in the Gut: From Invertebrates to Mammals
Kirsch, J. M., Brzozowski, R., Faith, D. R., Round, J. L., Secor, P. R., & Duerkop, B. A. (2021) · Annual Review of Virology · doi:10.1146/annurev-virology-091919-101238 · Cited by 55
Recent advances and emerging therapies in the non-surgical management of ulcerative colitis
Wehkamp, J., & Stange, E. F. (2018) · F1000Research · doi:10.12688/f1000research.15159.1 · Cited by 54
Yang, Z., Bu, C., Yuan, W., Shen, Z., Quan, Y., Wu, S., Zhu, C., & Wang, X. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05751-y · Cited by 54
Revisiting the intestinal microbiome and its role in Diarrhea and constipation
Iancu, M. A., Profir, M., Roşu, O. A., Ionescu, R. F., Cretoiu, S. M., & Gaspar, B. S. (2023) · Microorganisms · doi:10.3390/microorganisms11092177 · Cited by 53
Studying microbial functionality within the gut ecosystem by systems biology
Hornung, B., dos Santos, V. A. P. M., Smidt, H., & Schaap, P. J. (2018) · Genes & Nutrition · doi:10.1186/s12263-018-0594-6 · Cited by 60
New technologies for developing phage-based tools to manipulate the human microbiome
Khan Mirzaei, M., & Deng, L. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2021.04.007 · Cited by 53
Effects of bacteriophages on gut microbiome functionality
Kurilovich, E., & Geva-Zatorsky, N. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2481178 · Cited by 51
The gut microbiota in retinal diseases
Bringer, M.-A., Gabrielle, P., Bron, A. M., Creuzot-Garcher, C. P., & Acar, N. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108867 · Cited by 52
Intratumoral bacteria are an important “accomplice” in tumor development and metastasis
Wang, G., He, X., & Wang, Q. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188846 · Cited by 51
Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19
Neurath, M. F., Überla, K., & Ng, S. C. (2021) · Gut · doi:10.1136/gutjnl-2021-324622 · Cited by 50
Antibiotics, gut microbiota, environment in early life and type 1 diabetes
Hu, Y., Wong, F. S., & Li, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.034 · Cited by 50
Microbial modulation of the gut microbiome for treating autoimmune diseases
Balakrishnan, B., & Taneja, V. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1517044 · Cited by 51
Therapeutic Potential of the Gut Microbiota in the Management of Sepsis
Bassetti, M., Bandera, A., & Gori, A. (2020) · Critical Care · doi:10.1186/s13054-020-2780-3 · Cited by 53
Phages to shape the gut microbiota?
Dahlman, S., Avellaneda-Franco, L., & Barr, J. J. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.09.016 · Cited by 51
Enteric Phageome Alterations in Patients With Type 2 Diabetes
Chen, Q., Ma, X., Li, C., Shen, Y., Zhu, W., Zhang, Y., Guo, X., Zhou, J., & Liu, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.575084 · Cited by 51
Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults
Vasilescu, I.-M., Chifiriuc, M. C., Pîrcălăbioru, G. G., Filip, R., Bolocan, A., Lazăr, V., Diţu, L.-M., & Bleoţu, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.651081 · Cited by 53
Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future
Panchal, P., Budree, S., Scheeler, A., Medina, G., Seng, M., Wong, W. F., Eliott, R., Mitchell, T., Kassam, Z., Allegretti, J. R., et al. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0619-8 · Cited by 52
Review article: bacteriophages in gastroenterology—from biology to clinical applications
Sabino, J., Hirten, R. P., & Colombel, J. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15557 · Cited by 53
Therapeutic applications of lytic phages in human medicine
Guo, Z., Lin, H., Ji, X., Yan, G., Lei, L., Han, W., Gu, J., & Huang, J. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104048 · Cited by 52
Stripling, J. T., & Rodríguez, M. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.08.010 · Cited by 50
Park, H., Laffin, M., Jovel, J., Millan, B., Hyun, J. E., Hotte, N., Kao, D. H., & Madsen, K. L. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1586037 · Cited by 49
Manrique, P., Zhu, Y., John van der, O. O. S. T., Herrema, H., Nieuwdorp, M., de Vos, W. M., & Young, M. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1897217 · Cited by 49
Chu, N. D., Crothers, J. W., Nguyen, L. T. T., Kearney, S. M., Smith, M. B., Kassam, Z., Collins, C. C., Xavier, R. J., Moses, P. L., & Alm, E. J. (2021) · mBio · doi:10.1128/mbio.00975-21 · Cited by 53
An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases
Waller, K. M. J., Leong, R. W. L., & Paramsothy, S. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15731 · Cited by 49
High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients
Malard, F., Gasc, C., Plantamura, É., & Dore, J. M. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0254-x · Cited by 48
A theoretical model of temperate phages as mediators of gut microbiome dysbiosis
Lin, D. M., & Lin, H. C. (2019) · F1000Research · doi:10.12688/f1000research.18480.1 · Cited by 49
The Future of Microbiome‐Based Therapeutics in Clinical Applications
Sharma, A., Das, P., Buschmann, M. M., & Gilbert, J. A. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1677 · Cited by 50
Rasmussen, T. S., Mao, X., Forster, S., Larsen, S. B., von Münchow, A., Tranæs, K., Brunse, A., Larsen, F., Castro-Mejía, J. L., Adamberg, S., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01820-1 · Cited by 46
A Previously Undescribed Highly Prevalent Phage Identified in a Danish Enteric Virome Catalog
Espen, L. V., Bak, E. G., Beller, L., Close, L., Deboutte, W., Juel, H. B., Nielsen, T., Sinar, D., Coninck, L. D., Frithioff‐Bøjsøe, C., et al. (2021) · mSystems · doi:10.1128/msystems.00382-21 · Cited by 45
Gut Virome: Role and Distribution in Health and Gastrointestinal Diseases
Spencer, L. A., Olawuni, B., & Singh, P. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.836706 · Cited by 46
BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection
Solbach, P., Chhatwal, P., Woltemate, S., Tacconelli, E., Buhl, M. E. J., Gerhard, M., Thoeringer, C. K., Vehreschild, M. J. G. T., Jazmati, N., Rupp, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196977 · Cited by 48
Segal, J. P., Mullish, B. H., Quraishi, M. N., Iqbal, T. H., Marchesi, J. R., & Sokol, H. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820946904 · Cited by 51
Metadata
- Authors
- Ott, S. J., Waetzig, G. H., Rehman, A., Moltzau-Anderson, J., Bharti, R., Grasis, J. A., Cassidy, L., Tholey, A., Fickenscher, H., Seegert, D., Rosenstiel, P., & Schreiber, S.
- Affiliations
- University Hospital Schleswig-Holstein (DE)
- Conaris (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- San Diego State University (US)
- Corresponding author
- Schreiber, Stefan
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 152
- Issue
- 4
- Pages
- 799-811.e7
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2550586225
- Cited by
- 695
- References
- 54
- Citations by year
- 2026: 37 · 2025: 64 · 2024: 83 · 2023: 73 · 2022: 85 · 2021: 96 · 2020: 65 · 2019: 82 · 2018: 69 · 2017: 38
- FWCI
- 58.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Gastroenterology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (CRC 1182)
- Exzellenzclusters Entzündungsforschung
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, Clostridium difficile infection, recurrent Clostridium difficile infection, sterile filtration, bacteriophages, virome, microbiome, immunocompromised patients, bacterial community structure
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Aged, Enterocolitis, Pseudomembranous, Female, Filtration, Humans, Male, Middle Aged, Recurrence, Sterilization, Clostridioides difficile, Proteome, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review